(Q38202921)

30 August 2017

Genomic binding sites and biological effects of the vitamin D--VDR complex in multiple sclerosis [corrected]. (English)

1 reference

30 August 2017

0 references

0 references

Bernadette Kalman

1

1 reference

PubMed ID

24711208

30 August 2017

Erzsebet Toldy

series ordinal

2

1 reference

30 August 2017

8 April 2014

1 reference

30 August 2017

NeuroMolecular Medicine

1 reference

30 August 2017

16

1 reference

30 August 2017

2

1 reference

30 August 2017

265-279

1 reference

https://scigraph.springernature.com/pub.10.1007/s12017-014-8301-2

30 August 2017

0 references

cites work

Induction of tolerogenic dendritic cells by vitamin D receptor agonists

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Epstein-barr virus infection and multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Revealing the genetic basis of multiple sclerosis: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Pathway and network-based analysis of genome-wide association studies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

An integrated encyclopedia of DNA elements in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Intrinsic requirement for the vitamin D receptor in the development of CD8αα-expressing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D, invariant natural killer T-cells and experimental autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

The genetic epidemiology of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D: its role and uses in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Non-classical mechanisms of transcriptional regulation by the vitamin D receptor: insights into calcium homeostasis, immune system regulation and cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

The evidence for a role of B cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Genomic regions associated with multiple sclerosis are active in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D receptor binding, chromatin states and association with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Can we prevent or treat multiple sclerosis by individualised vitamin D supply?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Mapping and analysis of chromatin state dynamics in nine human cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D3 receptor ( VDR ) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Risk alleles for multiple sclerosis identified by a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Multiple sclerosis, vitamin D, and HLA-DRB1*15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Skp2 regulates Myc protein stability and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

The vitamin d receptor and T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

MicroRNA-mediated mechanism of vitamin D regulation of innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

1,25-Dihydroxyvitamin D3 induced histone profiles guide discovery of VDR action sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D status and gene transcription in immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

beta-catenin signaling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

One calcitriol dose transiently increases Helios+ FoxP3+ T cells and ameliorates autoimmune demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Rare variants in the CYP27B1 gene are associated with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D receptor as a master regulator of the c-MYC/MXD1 network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Timing of cigarette smoking as a risk factor for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

CCL2 induction by 1,25(OH)2D3 in dendritic cells from healthy donors and multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Trans-repression of beta-catenin activity by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

The molecular basis of vitamin D receptor and beta-catenin crossregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D as a T-cell modulator in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

The Ifng gene is essential for Vdr gene expression and vitamin D₃-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D: a pleiotropic hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D controls T cell antigen receptor signaling and activation of human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Twin concordance and sibling recurrence rates in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Vitamin D and the adaptive immune system with special emphasis to allergic reactions and allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Association of smoking with risk of multiple sclerosis: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8301-2

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

12 December 2020

Viruses and multiple sclerosis

1 reference

12 December 2020

Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol

1 reference

12 December 2020

AP-1 and vitamin D receptor (VDR) signaling pathways converge at the rat osteocalcin VDR element: requirement for the internal activating protein-1 site for vitamin D-mediated trans-activation

1 reference

12 December 2020

Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls

1 reference

12 December 2020

Characterization of multiple sclerosis traits: nuclear receptors (NR) impaired apoptosis pathway and the role of 1-α 25-dihydroxyvitamin D3

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis

1 reference

12 December 2020

10.1007/S12017-014-8301-2

Identifiers

DOI

1 reference

PubMed ID

24711208

Dimensions Publication ID

30 August 2017

0 references

1 reference

PubMed ID

24711208